Title |
Exploring the cancer genome in the era of next-generation sequencing
|
---|---|
Published in |
Frontiers of Medicine, March 2012
|
DOI | 10.1007/s11684-012-0182-x |
Pubmed ID | |
Authors |
Hui Dong, Shengyue Wang |
Abstract |
The emergence of next-generation sequencing technologies has led to dramatic advances in cancer genome studies. The increased efficiency and resolution of next-generation sequencing greatly facilitate the detection of genetic, genomic, and epigenomic alterations, such as single nucleotide mutations, small insertions and deletions, chromosomal rearrangements, copy number variations, and DNA methylation. Comprehensive analysis of cancer genomes through approaches of whole genome, exome, and transcriptome sequencing has significantly improved the understanding of cancer biology, diagnosis, and therapy. The present study briefly reviews the recent pioneering studies on cancer genome sequencing and provides an unprecedented insight into the landscape of genomic alterations in human sporadic cancers. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 50% |
Australia | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 50% |
Scientists | 1 | 50% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Portugal | 1 | 2% |
Netherlands | 1 | 2% |
Chile | 1 | 2% |
United Kingdom | 1 | 2% |
Mexico | 1 | 2% |
Unknown | 59 | 92% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 18 | 28% |
Student > Master | 10 | 16% |
Student > Ph. D. Student | 9 | 14% |
Professor > Associate Professor | 6 | 9% |
Student > Bachelor | 5 | 8% |
Other | 13 | 20% |
Unknown | 3 | 5% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 30 | 47% |
Medicine and Dentistry | 14 | 22% |
Biochemistry, Genetics and Molecular Biology | 10 | 16% |
Computer Science | 4 | 6% |
Social Sciences | 1 | 2% |
Other | 1 | 2% |
Unknown | 4 | 6% |